This assay clearly validated our findings from our tumor on‐a‐chip studies and scRNA‐seq analyses, where KYNU is responding to drive cancer cell migration in the presence of stromal and immune cells through activation of the KP pathway. This evidence concerns the gene NPPA and cancer.